{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:27:21Z","timestamp":1791329241075,"version":"4.3.1"},"reference-count":168,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nitric Oxide"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.niox.2022.07.006","type":"journal-article","created":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T12:14:53Z","timestamp":1659701693000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Impact of nitric oxide in liver cancer microenvironment"],"prefix":"10.1016","volume":"128","author":[{"given":"Sandra","family":"Dios-Barbeito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00fal","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miryam","family":"Cadenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisander F.","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor M.","family":"Victor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"Padillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Muntan\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.niox.2022.07.006_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22137068","article-title":"Nitric oxide modulates metabolic processes in the tumor immune microenvironment","volume":"22","author":"McGinity","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.niox.2022.07.006_bib2","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1096\/fj.10-179036","article-title":"Human primary bone sarcomas contain CD133+ cancer stem cells displaying high tumorigenicity in vivo","volume":"25","author":"Tirino","year":"2011","journal-title":"Faseb. J. : official publication of the Federation of American Societies for Experimental Biology"},{"issue":"4","key":"10.1016\/j.niox.2022.07.006_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010088","article-title":"A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype","volume":"5","author":"Waterman","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.niox.2022.07.006_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jcyt.2015.10.008","article-title":"The current landscape of the mesenchymal stromal cell secretome: a new paradigm for cell-free regeneration","volume":"18","author":"Konala","year":"2016","journal-title":"Cytotherapy"},{"issue":"2","key":"10.1016\/j.niox.2022.07.006_bib5","doi-asserted-by":"crossref","first-page":"715","DOI":"10.18632\/oncotarget.2711","article-title":"Cancer exosomes trigger mesenchymal stem cell differentiation into pro-angiogenic and pro-invasive myofibroblasts","volume":"6","author":"Chowdhury","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.niox.2022.07.006_bib6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1158\/1541-7786.MCR-21-0282","article-title":"Cancer-associated fibroblast subpopulations with diverse and dynamic roles in the tumor microenvironment","volume":"20","author":"Simon","year":"2022","journal-title":"Mol. Cancer Res.\u202f: MCR"},{"issue":"2","key":"10.1016\/j.niox.2022.07.006_bib7","first-page":"623","article-title":"Tumor-associated fibroblasts (part II): functional impact on tumor tissue","volume":"17","author":"Kunz-Schughart","year":"2002","journal-title":"Histol. Histopathol."},{"issue":"Pt 8","key":"10.1016\/j.niox.2022.07.006_bib8","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1242\/jcs.01000","article-title":"The stroma as a crucial target in rat mammary gland carcinogenesis","volume":"117","author":"Maffini","year":"2004","journal-title":"J. Cell Sci."},{"issue":"7467","key":"10.1016\/j.niox.2022.07.006_bib9","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature12626","article-title":"Influence of tumour micro-environment heterogeneity on therapeutic response","volume":"501","author":"Junttila","year":"2013","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.niox.2022.07.006_bib10","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12282-010-0234-5","article-title":"Role of stromal myofibroblasts in invasive breast cancer: stromal expression of alpha-smooth muscle actin correlates with worse clinical outcome","volume":"19","author":"Yamashita","year":"2012","journal-title":"Breast Cancer"},{"issue":"8","key":"10.1016\/j.niox.2022.07.006_bib11","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1097\/MPA.0b013e3181dbf647","article-title":"Alpha-smooth muscle actin expressing stroma promotes an aggressive tumor biology in pancreatic ductal adenocarcinoma","volume":"39","author":"Fujita","year":"2010","journal-title":"Pancreas"},{"issue":"21","key":"10.1016\/j.niox.2022.07.006_bib12","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1038\/s41388-019-0680-2","article-title":"Isolation and characterization of patient-derived CNS metastasis-associated stromal cell lines","volume":"38","author":"Tew","year":"2019","journal-title":"Oncogene"},{"issue":"24","key":"10.1016\/j.niox.2022.07.006_bib13","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1101\/gad.169029.111","article-title":"Immune microenvironments in solid tumors: new targets for therapy","volume":"25","author":"Shiao","year":"2011","journal-title":"Genes Dev."},{"issue":"12","key":"10.1016\/j.niox.2022.07.006_bib14","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1158\/1078-0432.CCR-12-0234","article-title":"CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer","volume":"18","author":"Nielsen","year":"2012","journal-title":"Clin. Cancer Res. : an official journal of the American Association for Cancer Research"},{"issue":"4","key":"10.1016\/j.niox.2022.07.006_bib15","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrc3245","article-title":"The immune contexture in human tumours: impact on clinical outcome","volume":"12","author":"Fridman","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.niox.2022.07.006_bib16","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.stem.2012.11.016","article-title":"MSCs, macrophages, and cancer: a dangerous menage-a-trois","volume":"11","author":"Mantovani","year":"2012","journal-title":"Cell Stem Cell"},{"issue":"15","key":"10.1016\/j.niox.2022.07.006_bib17","doi-asserted-by":"crossref","first-page":"20934","DOI":"10.18632\/oncotarget.8064","article-title":"Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects","volume":"7","author":"Jia","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.niox.2022.07.006_bib18","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.3390\/cancers6031670","article-title":"Tumor-associated macrophages as major players in the tumor microenvironment","volume":"6","author":"Chanmee","year":"2014","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.niox.2022.07.006_bib19","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/jnci\/djq044","article-title":"Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth","volume":"102","author":"Zhang","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.niox.2022.07.006_bib20","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1478-811X-8-24","article-title":"Environmental control of invasiveness and metastatic dissemination of tumor cells: the role of tumor cell-host cell interactions","volume":"8","author":"Calorini","year":"2010","journal-title":"Cell Commun. Signal."},{"issue":"1","key":"10.1016\/j.niox.2022.07.006_bib21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12943-017-0597-8","article-title":"Mesenchymal stem cells: key players in cancer progression","volume":"16","author":"Ridge","year":"2017","journal-title":"Mol. Cancer"},{"issue":"10","key":"10.1016\/j.niox.2022.07.006_bib22","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1634\/stemcells.2007-0226","article-title":"Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis","volume":"25","author":"Wu","year":"2007","journal-title":"Stem Cell."},{"issue":"2","key":"10.1016\/j.niox.2022.07.006_bib23","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ccr.2011.01.020","article-title":"Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth","volume":"19","author":"Quante","year":"2011","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.niox.2022.07.006_bib24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/jbm.b.30065","article-title":"Porous alginate\/hydroxyapatite composite scaffolds for bone tissue engineering: preparation, characterization, and in vitro studies","volume":"71","author":"Lin","year":"2004","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"issue":"1","key":"10.1016\/j.niox.2022.07.006_bib25","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.yexcr.2013.10.013","article-title":"Osteosarcoma cells promote the production of pro-tumor cytokines in mesenchymal stem cells by inhibiting their osteogenic differentiation through the TGF-beta\/Smad2\/3 pathway","volume":"320","author":"Tu","year":"2014","journal-title":"Exp. Cell Res."},{"issue":"7162","key":"10.1016\/j.niox.2022.07.006_bib26","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature06188","article-title":"Mesenchymal stem cells within tumour stroma promote breast cancer metastasis","volume":"449","author":"Karnoub","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.niox.2022.07.006_bib27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-3-030-40146-7_5","article-title":"Matrix metalloproteinases' role in tumor microenvironment","volume":"1245","author":"Gonzalez-Avila","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.niox.2022.07.006_bib28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.critrevonc.2019.02.010","article-title":"Matrix metalloproteinases participation in the metastatic process and their diagnostic and therapeutic applications in cancer","volume":"137","author":"Gonzalez-Avila","year":"2019","journal-title":"Crit. Rev. Oncol.-Hematol."},{"issue":"23","key":"10.1016\/j.niox.2022.07.006_bib29","doi-asserted-by":"crossref","first-page":"10862","DOI":"10.1158\/0008-5472.CAN-05-1231","article-title":"Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell-adipocyte interaction\/crosstalk at the tumor invasive front","volume":"65","author":"Andarawewa","year":"2005","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.niox.2022.07.006_bib30","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/ijc.25309","article-title":"Matrix metalloproteinase 11\/stromelysin-3 exerts both activator and repressor functions during the hematogenous metastatic process in mice","volume":"127","author":"Brasse","year":"2010","journal-title":"International journal of cancer Journal international du cancer"},{"issue":"2","key":"10.1016\/j.niox.2022.07.006_bib31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.5301\/JBM.5000026","article-title":"Potential clinical applications of matrix metalloproteinase inhibitors and their future prospects","volume":"28","author":"Li","year":"2013","journal-title":"Int. J. Biol. Markers"},{"issue":"2","key":"10.1016\/j.niox.2022.07.006_bib32","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1517\/17425255.2016.1131820","article-title":"Pharmacodynamic considerations in the use of matrix metalloproteinase inhibitors in cancer treatment","volume":"12","author":"Yang","year":"2016","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"issue":"8","key":"10.1016\/j.niox.2022.07.006_bib33","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1134\/S0006297917080016","article-title":"Components of the hepatocellular carcinoma microenvironment and their role in tumor progression","volume":"82","author":"Novikova","year":"2017","journal-title":"Biochemistry Biokhimiia"},{"issue":"5","key":"10.1016\/j.niox.2022.07.006_bib34","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.dld.2021.07.006","article-title":"Intercellular crosstalk of liver sinusoidal endothelial cells in liver fibrosis, cirrhosis and hepatocellular carcinoma","volume":"54","author":"Li","year":"2022","journal-title":"Dig. Liver Dis."},{"issue":"5","key":"10.1016\/j.niox.2022.07.006_bib35","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrc1877","article-title":"Fibroblasts in cancer","volume":"6","author":"Kalluri","year":"2006","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.niox.2022.07.006_bib36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.semcdb.2009.10.002","article-title":"Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression","volume":"21","author":"Shimoda","year":"2010","journal-title":"Semin. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.niox.2022.07.006_bib37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.canlet.2016.05.022","article-title":"Cancer-associated fibroblasts promote hepatocellular carcinoma metastasis through chemokine-activated hedgehog and TGF-beta pathways","volume":"379","author":"Liu","year":"2016","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.niox.2022.07.006_bib38","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ejso.2020.08.002","article-title":"Cancer-associated fibroblasts promote hepatocellular carcinoma progression through downregulation of exosomal miR-150-3p","volume":"47","author":"Yugawa","year":"2021","journal-title":"Eur. J. Surg. Oncol. : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology"},{"issue":"1","key":"10.1016\/j.niox.2022.07.006_bib39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s11658-022-00309-9","article-title":"Exosomal lncRNA TUG1 from cancer-associated fibroblasts promotes liver cancer cell migration, invasion, and glycolysis by regulating the miR-524-5p\/SIX1 axis","volume":"27","author":"Lu","year":"2022","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"3","key":"10.1016\/j.niox.2022.07.006_bib40","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/hep.29586","article-title":"Exosome miR-335 as a novel therapeutic strategy in hepatocellular carcinoma","volume":"67","author":"Wang","year":"2018","journal-title":"Hepatology"},{"issue":"24","key":"10.1016\/j.niox.2022.07.006_bib41","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.4161\/cbt.8.24.9985","article-title":"Involvement of glypican-3 in the recruitment of M2-polarized tumor-associated macrophages in hepatocellular carcinoma","volume":"8","author":"Takai","year":"2009","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.niox.2022.07.006_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/CGM.S14205","article-title":"TGF-Beta mediated crosstalk between malignant hepatocyte and tumor microenvironment in hepatocellular carcinoma","volume":"7","author":"Gupta","year":"2014","journal-title":"Cancer Growth Metastasis"},{"issue":"6","key":"10.1016\/j.niox.2022.07.006_bib43","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/j.gastro.2014.08.039","article-title":"Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells","volume":"147","author":"Wan","year":"2014","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.niox.2022.07.006_bib44","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4254\/wjh.v2.i5.175","article-title":"Innovative immunohistochemistry identifies MMP-9 expressing macrophages at the invasive front of murine HCC","volume":"2","author":"Roderfeld","year":"2010","journal-title":"World J. Hepatol."},{"issue":"6","key":"10.1016\/j.niox.2022.07.006_bib45","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.3892\/or.2014.3138","article-title":"Role of tumor-associated macrophages in the angiogenesis of well-differentiated hepatocellular carcinoma: pathological-radiological correlation","volume":"31","author":"Fujita","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.niox.2022.07.006_bib46","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2172-12-43","article-title":"Transition of tumor-associated macrophages from MHC class II(hi) to MHC class II(low) mediates tumor progression in mice","volume":"12","author":"Wang","year":"2011","journal-title":"BMC Immunol."},{"issue":"8","key":"10.1016\/j.niox.2022.07.006_bib47","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/s41419-018-0818-0","article-title":"Crosstalk between hepatic tumor cells and macrophages via Wnt\/beta-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors","volume":"9","author":"Yang","year":"2018","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.niox.2022.07.006_bib48","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1002\/hep.26328","article-title":"Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells","volume":"57","author":"Sprinzl","year":"2013","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.niox.2022.07.006_bib49","first-page":"101","article-title":"Upregulation of B7-H1 expression is associated with macrophage infiltration in hepatocellular carcinomas. Cancer immunology, immunotherapy","volume":"61","author":"Chen","year":"2012","journal-title":"CII"},{"key":"10.1016\/j.niox.2022.07.006_bib50","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.3389\/fimmu.2019.01643","article-title":"M1 macrophages induce PD-L1 expression in hepatocellular carcinoma cells through IL-1beta signaling","volume":"10","author":"Zong","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.niox.2022.07.006_bib51","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1182\/blood-2006-02-002246","article-title":"Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells","volume":"109","author":"Sato","year":"2007","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.niox.2022.07.006_bib52","doi-asserted-by":"crossref","first-page":"30193","DOI":"10.18632\/oncotarget.8623","article-title":"Human mesenchymal stromal cell-secreted lactate induces M2-macrophage differentiation by metabolic reprogramming","volume":"7","author":"Selleri","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.niox.2022.07.006_bib53","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1634\/stemcells.2004-0359","article-title":"Interactions between human mesenchymal stem cells and natural killer cells","volume":"24","author":"Sotiropoulou","year":"2006","journal-title":"Stem Cell."},{"issue":"5","key":"10.1016\/j.niox.2022.07.006_bib54","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.stem.2012.03.007","article-title":"Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-\/FAS-mediated T cell apoptosis","volume":"10","author":"Akiyama","year":"2012","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.niox.2022.07.006_bib55","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s13046-019-1219-7","article-title":"The hypoxia conditioned mesenchymal stem cells promote hepatocellular carcinoma progression through YAP mediated lipogenesis reprogramming","volume":"38","author":"Liu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res. : CR (Clim. Res.)"},{"issue":"3","key":"10.1016\/j.niox.2022.07.006_bib56","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.surg.2012.06.011","article-title":"Human mesenchymal stem cell and epithelial hepatic carcinoma cell lines in admixture: concurrent stimulation of cancer-associated fibroblasts and epithelial-to-mesenchymal transition markers","volume":"152","author":"Bhattacharya","year":"2012","journal-title":"Surgery"},{"issue":"37","key":"10.1016\/j.niox.2022.07.006_bib57","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1038\/onc.2014.410","article-title":"Osteopontin mediates an MZF1-TGF-beta1-dependent transformation of mesenchymal stem cells into cancer-associated fibroblasts in breast cancer","volume":"34","author":"Weber","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.niox.2022.07.006_bib58","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1146\/annurev-pathol-052016-100322","article-title":"The role of cancer-associated fibroblasts and fibrosis in liver cancer","volume":"12","author":"Affo","year":"2017","journal-title":"Annu. Rev. Pathol."},{"issue":"9","key":"10.1016\/j.niox.2022.07.006_bib59","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1158\/0008-5472.CAN-19-3158","article-title":"NOX4 inhibition potentiates immunotherapy by overcoming cancer-associated fibroblast-mediated CD8 T-cell exclusion from tumors","volume":"80","author":"Ford","year":"2020","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.niox.2022.07.006_bib60","doi-asserted-by":"crossref","first-page":"a006536","DOI":"10.1101\/cshperspect.a006536","article-title":"Tumor endothelial cells","volume":"2","author":"Dudley","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"5","key":"10.1016\/j.niox.2022.07.006_bib61","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/S0002-9440(10)63540-7","article-title":"Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors","volume":"163","author":"Baluk","year":"2003","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.niox.2022.07.006_bib62","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1124\/mol.116.107706","article-title":"Advances in hypoxia-mediated mechanisms in hepatocellular carcinoma","volume":"92","author":"Xiong","year":"2017","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.niox.2022.07.006_bib63","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1158\/1078-0432.CCR-18-1254","article-title":"The role of angiogenesis in hepatocellular carcinoma","volume":"25","author":"Morse","year":"2019","journal-title":"Clin. Cancer Res. : an official journal of the American Association for Cancer Research"},{"issue":"10","key":"10.1016\/j.niox.2022.07.006_bib64","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1002\/bjs.4594","article-title":"Prognostic significance of serum vascular endothelial growth factor and endostatin in patients with hepatocellular carcinoma","volume":"91","author":"Poon","year":"2004","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.niox.2022.07.006_bib65","first-page":"1927","article-title":"Angiopoietin 2 as a therapeutic target in hepatocellular carcinoma treatment: current perspectives","volume":"7","author":"Bupathi","year":"2014","journal-title":"OncoTargets Ther."},{"issue":"11","key":"10.1016\/j.niox.2022.07.006_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143657","article-title":"Tie2-Expressing monocytes are associated with identification and prognoses of hepatitis B virus related hepatocellular carcinoma after resection","volume":"10","author":"He","year":"2015","journal-title":"PLoS One"},{"issue":"7 Pt 2","key":"10.1016\/j.niox.2022.07.006_bib67","first-page":"e157","article-title":"Angiopoietin-2 levels in the hepatic vein as a useful predictor of tumor invasiveness and prognosis in human hepatocellular carcinoma","volume":"23","author":"Kuboki","year":"2008","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"12","key":"10.1016\/j.niox.2022.07.006_bib68","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1136\/gut.2005.067900","article-title":"Angiopoietin 2 displays a vascular endothelial growth factor dependent synergistic effect in hepatocellular carcinoma development in mice","volume":"54","author":"Yoshiji","year":"2005","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.niox.2022.07.006_bib69","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/jgh.12702","article-title":"ANGPTL2 promotes tumor metastasis in hepatocellular carcinoma","volume":"30","author":"Gao","year":"2015","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.niox.2022.07.006_bib70","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.niox.2022.07.006_bib71","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bpg.2011.02.006","article-title":"Liver fibrogenic cells","volume":"25","author":"Forbes","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"issue":"62","key":"10.1016\/j.niox.2022.07.006_bib72","doi-asserted-by":"crossref","first-page":"105340","DOI":"10.18632\/oncotarget.22186","article-title":"Agrin para-secreted by PDGF-activated human hepatic stellate cells promotes hepatocarcinogenesis in vitro and in vivo","volume":"8","author":"Lv","year":"2017","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.niox.2022.07.006_bib73","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1158\/0008-5472.CAN-11-3317","article-title":"Hepatocyte-stellate cell cross-talk in the liver engenders a permissive inflammatory microenvironment that drives progression in hepatocellular carcinoma","volume":"72","author":"Coulouarn","year":"2012","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.niox.2022.07.006_bib74","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/liv.12465","article-title":"Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever","volume":"34","author":"Carloni","year":"2014","journal-title":"Liver Int. : official journal of the International Association for the Study of the Liver"},{"key":"10.1016\/j.niox.2022.07.006_bib75","doi-asserted-by":"crossref","first-page":"7916","DOI":"10.1038\/srep07916","article-title":"Angiogenin secretion from hepatoma cells activates hepatic stellate cells to amplify a self-sustained cycle promoting liver cancer","volume":"5","author":"Barcena","year":"2015","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.niox.2022.07.006_bib76","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/jcb.29380","article-title":"Activated hepatic stellate cells promote angiogenesis in hepatocellular carcinoma by secreting angiopoietin-1","volume":"121","author":"Lin","year":"2020","journal-title":"J. Cell. Biochem."},{"issue":"4","key":"10.1016\/j.niox.2022.07.006_bib77","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1215\/S1152851705000232","article-title":"The role of pericytes in blood-vessel formation and maintenance","volume":"7","author":"Bergers","year":"2005","journal-title":"Neuro Oncol."},{"issue":"2","key":"10.1016\/j.niox.2022.07.006_bib78","doi-asserted-by":"crossref","first-page":"743","DOI":"10.21873\/anticanres.14005","article-title":"Hepatic stellate cells contribute to the tumor malignancy of hepatocellular carcinoma through the IL-6 pathway","volume":"40","author":"Iwahasi","year":"2020","journal-title":"Anticancer Res."},{"key":"10.1016\/j.niox.2022.07.006_bib79","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.canlet.2020.02.012","article-title":"Hepatic stellate cells promote the progression of hepatocellular carcinoma through microRNA-1246-RORalpha-Wnt\/beta-Catenin axis","volume":"476","author":"Huang","year":"2020","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.niox.2022.07.006_bib80","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1002\/hep.28835","article-title":"Hepatic stellate cells induce hepatocellular carcinoma cell resistance to sorafenib through the laminin-332\/alpha3 integrin axis recovery of focal adhesion kinase ubiquitination","volume":"64","author":"Azzariti","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.niox.2022.07.006_bib81","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1038\/s41598-020-61510-4","article-title":"Fibroblast Growth Factor 9 is expressed by activated hepatic stellate cells and promotes progression of hepatocellular carcinoma","volume":"10","author":"Seitz","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.niox.2022.07.006_bib82","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/s13046-018-0965-2","article-title":"Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts","volume":"37","author":"Zhou","year":"2018","journal-title":"J. Exp. Clin. Cancer Res. : CR (Clim. Res.)"},{"issue":"6","key":"10.1016\/j.niox.2022.07.006_bib83","doi-asserted-by":"crossref","first-page":"741","DOI":"10.15252\/emmm.201607222","article-title":"Hepatic stellate cells limit hepatocellular carcinoma progression through the orphan receptor endosialin","volume":"9","author":"Mogler","year":"2017","journal-title":"EMBO Mol. Med."},{"issue":"3","key":"10.1016\/j.niox.2022.07.006_bib84","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41590-018-0044-z","article-title":"The immunology of hepatocellular carcinoma","volume":"19","author":"Ringelhan","year":"2018","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.niox.2022.07.006_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14030621","article-title":"Hepatocellular carcinoma: molecular pathogenesis and therapeutic advances","volume":"14","author":"Cucarull","year":"2022","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.niox.2022.07.006_bib86","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/hep.27867","article-title":"Myeloid cells in hepatocellular carcinoma","volume":"62","author":"Wan","year":"2015","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.niox.2022.07.006_bib87","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/bjc.2017.220","article-title":"HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer","volume":"117","author":"Barnes","year":"2017","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.niox.2022.07.006_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/cells10061332","article-title":"Natural killer cells and T cells in hepatocellular carcinoma and viral hepatitis: current status and perspectives for future immunotherapeutic approaches","volume":"10","author":"Kalathil","year":"2021","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.niox.2022.07.006_bib89","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.ajpath.2022.02.004","article-title":"The functional roles of immune cells in primary liver cancer","volume":"192","author":"Pham","year":"2022","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.niox.2022.07.006_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.643310","article-title":"Natural killer cells and regulatory T cells cross talk in hepatocellular carcinoma: exploring therapeutic options for the next decade","volume":"12","author":"Bozward","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.niox.2022.07.006_bib91","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.647854","article-title":"Current perspectives on B lymphocytes in the immunobiology of hepatocellular carcinoma","volume":"11","author":"Qin","year":"2021","journal-title":"Front. Oncol."},{"issue":"20","key":"10.1016\/j.niox.2022.07.006_bib92","doi-asserted-by":"crossref","first-page":"8067","DOI":"10.1158\/0008-5472.CAN-09-0901","article-title":"Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1\/programmed death-1 interactions","volume":"69","author":"Wu","year":"2009","journal-title":"Cancer Res."},{"issue":"25","key":"10.1016\/j.niox.2022.07.006_bib93","doi-asserted-by":"crossref","first-page":"8048","DOI":"10.3748\/wjg.v20.i25.8048","article-title":"Fibrogenesis in alcoholic liver disease","volume":"20","author":"Fujii","year":"2014","journal-title":"World J. Gastroenterol. : WJG"},{"key":"10.1016\/j.niox.2022.07.006_bib94","article-title":"Mesenchymal stem cell-derived extracellular vesicles in liver immunity and therapy","volume":"13","author":"Wu","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.niox.2022.07.006_bib95","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J. Hepatol."},{"issue":"21","key":"10.1016\/j.niox.2022.07.006_bib96","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13215295","article-title":"Cure the incurable? Recent breakthroughs in immune checkpoint blockade for hepatocellular carcinoma","volume":"13","author":"Chu","year":"2021","journal-title":"Cancers"},{"issue":"17","key":"10.1016\/j.niox.2022.07.006_bib97","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1038\/s41388-022-02264-3","article-title":"The proteomic characterization of the peritumor microenvironment in human hepatocellular carcinoma","volume":"41","author":"Gu","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.niox.2022.07.006_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.semcancer.2022.02.015","article-title":"Chemokine clouding and liver cancer heterogeneity: does it impact clinical outcomes?","author":"Ahmad","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"3","key":"10.1016\/j.niox.2022.07.006_bib99","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41419-022-04689-w","article-title":"Single cell transcriptional diversity and intercellular crosstalk of human liver cancer","volume":"13","author":"Meng","year":"2022","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.niox.2022.07.006_bib100","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.trecan.2022.02.009","article-title":"The gut-liver axis: host microbiota interactions shape hepatocarcinogenesis","volume":"8","author":"Silveira","year":"2022","journal-title":"Trends Cancer"},{"issue":"2","key":"10.1016\/j.niox.2022.07.006_bib101","doi-asserted-by":"crossref","first-page":"C89","DOI":"10.1152\/ajpcell.00187.2014","article-title":"Nitric oxide induces cancer stem cell-like phenotypes in human lung cancer cells","volume":"308","author":"Yongsanguanchai","year":"2015","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"3","key":"10.1016\/j.niox.2022.07.006_bib102","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.bbrc.2015.01.154","article-title":"Flavone inhibits nitric oxide synthase (NOS) activity, nitric oxide production and protein S-nitrosylation in breast cancer cells","volume":"458","author":"Zhu","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1\u20132","key":"10.1016\/j.niox.2022.07.006_bib103","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.canlet.2014.03.014","article-title":"Secondary stimulation from Bacillus Calmette-Guerin induced macrophages induce nitric oxide independent cell-death in bladder cancer cells","volume":"348","author":"Thiel","year":"2014","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.niox.2022.07.006_bib104","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/pin.12152","article-title":"Induced nitric oxide synthetase and peroxiredoxin expression in intramucosal poorly differentiated gastric cancer of young patients","volume":"64","author":"Hirahashi","year":"2014","journal-title":"Pathol. Int."},{"issue":"1","key":"10.1016\/j.niox.2022.07.006_bib105","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.canlet.2012.09.006","article-title":"Increased expression of activated endothelial nitric oxide synthase contributes to antiandrogen resistance in prostate cancer cells by suppressing androgen receptor transactivation","volume":"328","author":"Yu","year":"2013","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.niox.2022.07.006_bib106","doi-asserted-by":"crossref","first-page":"762","DOI":"10.2174\/1566524014666140724103147","article-title":"Upregulation of cytoskeleton protein and extracellular matrix protein induced by stromal-derived nitric oxide promotes lung cancer invasion and metastasis","volume":"14","author":"Zhang","year":"2014","journal-title":"Curr. Mol. Med."},{"issue":"4","key":"10.1016\/j.niox.2022.07.006_bib107","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s13277-012-0332-4","article-title":"Discriminant function based on parameters of hyaluronic acid metabolism and nitric oxide to differentiate metastatic from non-metastatic colorectal cancer patients","volume":"33","author":"El-Mezayen","year":"2012","journal-title":"Tumour Biol"},{"issue":"6","key":"10.1016\/j.niox.2022.07.006_bib108","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.3892\/ol.2014.2607","article-title":"Nitric oxide signaling pathway activation inhibits the immune escape of pancreatic carcinoma cells","volume":"8","author":"Lu","year":"2014","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.niox.2022.07.006_bib109","doi-asserted-by":"crossref","first-page":"638","DOI":"10.3892\/ijo.2013.1985","article-title":"Ectopic expression of the TERE1 (UBIAD1) protein inhibits growth of renal clear cell carcinoma cells: altered metabolic phenotype associated with reactive oxygen species, nitric oxide and SXR target genes involved in cholesterol and lipid metabolism","volume":"43","author":"Fredericks","year":"2013","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.niox.2022.07.006_bib110","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/hep.510260120","article-title":"Nitric oxide formation lowers norepinephrine-induced intrahepatic resistance without major effects on the metabolism in the perfused rat liver","volume":"26","author":"Weidenbach","year":"1997","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.niox.2022.07.006_bib111","doi-asserted-by":"crossref","DOI":"10.3390\/metabo10110429","article-title":"Nitric oxide in macrophage immunometabolism: hiding in plain sight","volume":"10","author":"Palmieri","year":"2020","journal-title":"Metabolites"},{"issue":"13","key":"10.1016\/j.niox.2022.07.006_bib112","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1089\/ars.2017.7072","article-title":"Regulation of cell survival, apoptosis, and epithelial-to-mesenchymal transition by nitric oxide-dependent post-translational modifications","volume":"29","author":"Gonzalez","year":"2018","journal-title":"Antioxidants Redox Signal."},{"issue":"7\u20138","key":"10.1016\/j.niox.2022.07.006_bib113","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1089\/ars.2006.8.1329","article-title":"The biphasic nature of nitric oxide responses in tumor biology","volume":"8","author":"Ridnour","year":"2006","journal-title":"Antioxidants Redox Signal."},{"issue":"1","key":"10.1016\/j.niox.2022.07.006_bib114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/BC.2004.001","article-title":"The chemistry of nitrosative stress induced by nitric oxide and reactive nitrogen oxide species. Putting perspective on stressful biological situations","volume":"385","author":"Ridnour","year":"2004","journal-title":"Biol. Chem."},{"issue":"1","key":"10.1016\/j.niox.2022.07.006_bib115","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.freeradbiomed.2008.03.020","article-title":"The chemical biology of nitric oxide: implications in cellular signaling","volume":"45","author":"Thomas","year":"2008","journal-title":"Free Radic. Biol. Med."},{"issue":"33","key":"10.1016\/j.niox.2022.07.006_bib116","doi-asserted-by":"crossref","first-page":"52993","DOI":"10.18632\/oncotarget.10323","article-title":"Inducible nitric oxide synthase enhances disease aggressiveness in pancreatic cancer","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.niox.2022.07.006_bib117","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1158\/1541-7786.MCR-12-0124","article-title":"S-nitrosylation of EGFR and Src activates an oncogenic signaling network in human basal-like breast cancer","volume":"10","author":"Switzer","year":"2012","journal-title":"Mol. Cancer Res. : MCR"},{"issue":"24","key":"10.1016\/j.niox.2022.07.006_bib118","doi-asserted-by":"crossref","first-page":"8894","DOI":"10.1073\/pnas.0400453101","article-title":"Hypoxic inducible factor 1alpha, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide","volume":"101","author":"Thomas","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.niox.2022.07.006_bib119","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/jnci\/91.1.86","article-title":"Relationship between p53 mutations and inducible nitric oxide synthase expression in human colorectal cancer","volume":"91","author":"Ambs","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"issue":"3","key":"10.1016\/j.niox.2022.07.006_bib120","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1470-2045(00)00256-4","article-title":"Role of nitric oxide in carcinogenesis and tumour progression","volume":"2","author":"Lala","year":"2001","journal-title":"Lancet Oncol."},{"issue":"45","key":"10.1016\/j.niox.2022.07.006_bib121","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1038\/onc.2008.271","article-title":"The tumor microenvironment and its role in promoting tumor growth","volume":"27","author":"Whiteside","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.niox.2022.07.006_bib122","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.trsl.2019.03.003","article-title":"Immunomodulatory roles of nitric oxide in cancer: tumor microenvironment says \"NO\" to antitumor immune response","volume":"210","author":"PeNarando","year":"2019","journal-title":"Transl. Res."},{"issue":"7","key":"10.1016\/j.niox.2022.07.006_bib123","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrc1910","article-title":"The role of nitric oxide in tumour progression","volume":"6","author":"Fukumura","year":"2006","journal-title":"Nat. Rev. Cancer"},{"issue":"38","key":"10.1016\/j.niox.2022.07.006_bib124","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.3748\/wjg.v11.i38.5931","article-title":"Expressions of inducible nitric oxide synthase and matrix metalloproteinase-9 and their effects on angiogenesis and progression of hepatocellular carcinoma","volume":"11","author":"Sun","year":"2005","journal-title":"World J. Gastroenterol. : WJG"},{"issue":"12","key":"10.1016\/j.niox.2022.07.006_bib125","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126264","article-title":"Role of nitric oxide in gene expression regulation during cancer: epigenetic modifications and non-coding RNAs","volume":"22","author":"de la Cruz-Ojeda","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.niox.2022.07.006_bib126","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cyto.2018.02.002","article-title":"Melanoma exosomes promote mixed M1 and M2 macrophage polarization","volume":"105","author":"Bardi","year":"2018","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.niox.2022.07.006_bib127","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.celrep.2019.06.018","article-title":"Nitric oxide modulates metabolic remodeling in inflammatory macrophages through TCA cycle regulation and itaconate accumulation","volume":"28","author":"Bailey","year":"2019","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.niox.2022.07.006_bib128","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.bbrc.2019.05.114","article-title":"Mitochondrial NOS1 suppresses apoptosis in colon cancer cells through increasing SIRT3 activity","volume":"515","author":"Wang","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.niox.2022.07.006_bib129","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/cas.13945","article-title":"Nitric oxide inhibits autophagy and promotes apoptosis in hepatocellular carcinoma","volume":"110","author":"Zhang","year":"2019","journal-title":"Cancer Sci."},{"key":"10.1016\/j.niox.2022.07.006_bib130","article-title":"NOS1 S-nitrosylates PTEN and inhibits autophagy in nasopharyngeal carcinoma cells","volume":"3","author":"Zhu","year":"2017","journal-title":"Cell Death Dis."},{"issue":"11","key":"10.1016\/j.niox.2022.07.006_bib131","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1158\/0008-5472.CAN-13-2740","article-title":"Cancer-associated fibroblasts expressing CXCL14 rely upon NOS1-derived nitric oxide signaling for their tumor-supporting properties","volume":"74","author":"Augsten","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.niox.2022.07.006_bib132","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1477-7819-11-118","article-title":"Nitric oxide and cancer: a review","volume":"11","author":"Choudhari","year":"2013","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.niox.2022.07.006_bib133","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.643529","article-title":"Distinct stromal and immune features collectively contribute to long-term survival in pancreatic cancer","volume":"12","author":"Sadozai","year":"2021","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.niox.2022.07.006_bib134","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw292","article-title":"Role of RPL39 in metaplastic breast cancer","volume":"109","author":"Dave","year":"2017","journal-title":"J. Natl. Cancer Inst."},{"issue":"5","key":"10.1016\/j.niox.2022.07.006_bib135","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1158\/1078-0432.CCR-17-1437","article-title":"Pharmacological inhibition of NOS activates ASK1\/JNK pathway augmenting docetaxel-mediated apoptosis in triple-negative breast cancer","volume":"24","author":"Davila-Gonzalez","year":"2018","journal-title":"Clin. Cancer Res. : an official journal of the American Association for Cancer Research"},{"issue":"1","key":"10.1016\/j.niox.2022.07.006_bib136","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/med.21599","article-title":"Inducible nitric oxide synthase: regulation, structure, and inhibition","volume":"40","author":"Cinelli","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.niox.2022.07.006_bib137","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.redox.2015.08.009","article-title":"The dual role of iNOS in cancer","volume":"6","author":"Vannini","year":"2015","journal-title":"Redox Biol."},{"issue":"6","key":"10.1016\/j.niox.2022.07.006_bib138","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3892\/mmr.2012.1096","article-title":"Decreased levels of nitric oxide production and nitric oxide synthase-2 expression are associated with the development and metastasis of hepatocellular carcinoma","volume":"6","author":"Zhou","year":"2012","journal-title":"Mol. Med. Rep."},{"issue":"43","key":"10.1016\/j.niox.2022.07.006_bib139","doi-asserted-by":"crossref","first-page":"E10127","DOI":"10.1073\/pnas.1722100115","article-title":"iNOS promotes CD24(+)CD133(+) liver cancer stem cell phenotype through a TACE\/ADAM17-dependent Notch signaling pathway","volume":"115","author":"Wang","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.niox.2022.07.006_bib140","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.redox.2015.07.007","article-title":"Redox regulation of metabolic and signaling pathways by thioredoxin and glutaredoxin in NOS-3 overexpressing hepatoblastoma cells","volume":"6","author":"Gonzalez","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.niox.2022.07.006_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101528","article-title":"Downregulation of thioredoxin-1-dependent CD95 S-nitrosation by Sorafenib reduces liver cancer","volume":"34","author":"Gonzalez","year":"2020","journal-title":"Redox Biol."},{"issue":"8","key":"10.1016\/j.niox.2022.07.006_bib142","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/carcin\/bgn155","article-title":"Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease","volume":"29","author":"Calvisi","year":"2008","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.niox.2022.07.006_bib143","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2014.07.014","article-title":"Nitric oxide in cancer metastasis","volume":"353","author":"Cheng","year":"2014","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.niox.2022.07.006_bib144","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jhep.2010.10.022","article-title":"Nitric oxide mimics transcriptional and post-translational regulation during alpha-tocopherol cytoprotection against glycochenodeoxycholate-induced cell death in hepatocytes","volume":"55","author":"Gonzalez","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.niox.2022.07.006_bib145","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.redox.2015.07.010","article-title":"Regulation of cell death receptor S-nitrosylation and apoptotic signaling by Sorafenib in hepatoblastoma cells","volume":"6","author":"Rodriguez-Hernandez","year":"2015","journal-title":"Redox Biol."},{"issue":"3","key":"10.1016\/j.niox.2022.07.006_bib146","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/FJC.0b013e3181b72c9f","article-title":"S-Nitrosylation of cardiac ion channels","volume":"54","author":"Gonzalez","year":"2009","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"11","key":"10.1016\/j.niox.2022.07.006_bib147","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1073\/pnas.1113319109","article-title":"Dynamic denitrosylation via S-nitrosoglutathione reductase regulates cardiovascular function","volume":"109","author":"Beigi","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5\u20136","key":"10.1016\/j.niox.2022.07.006_bib148","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1615\/CritRevOncog.2017021074","article-title":"Tumor suppressor roles of the denitrosylase GSNOR","volume":"21","author":"Rizza","year":"2016","journal-title":"Crit. Rev. Oncog."},{"issue":"9","key":"10.1016\/j.niox.2022.07.006_bib149","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1158\/0008-5472.CAN-12-3980","article-title":"Hepatocarcinogenesis driven by GSNOR deficiency is prevented by iNOS inhibition","volume":"73","author":"Tang","year":"2013","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.niox.2022.07.006_bib150","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1007\/s11010-020-04032-x","article-title":"Exogenous NO induces apoptosis of hepatocellular carcinoma cells via positive p38\/JNK signaling pathway and negative ERK signaling pathways","volume":"476","author":"Liu","year":"2021","journal-title":"Mol. Cell. Biochem."},{"issue":"5","key":"10.1016\/j.niox.2022.07.006_bib151","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1089\/ars.2011.4476","article-title":"Targeting hepatoma using nitric oxide donor strategies","volume":"18","author":"Gonzalez","year":"2013","journal-title":"Antioxidants Redox Signal."},{"issue":"1","key":"10.1016\/j.niox.2022.07.006_bib152","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/gt.2015.79","article-title":"Antitumoral gene-based strategy involving nitric oxide synthase type III overexpression in hepatocellular carcinoma","volume":"23","author":"De la Rosa","year":"2016","journal-title":"Gene Ther."},{"issue":"3","key":"10.1016\/j.niox.2022.07.006_bib153","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ccr.2012.03.003","article-title":"Cancer stem cells: impact, heterogeneity, and uncertainty","volume":"21","author":"Magee","year":"2012","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.niox.2022.07.006_bib154","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.bbrc.2013.04.071","article-title":"iNOS promotes HBx-induced hepatocellular carcinoma via upregulation of JNK activation","volume":"435","author":"Park","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.niox.2022.07.006_bib155","doi-asserted-by":"crossref","first-page":"6980","DOI":"10.1074\/jbc.M109.065987","article-title":"Stimulation of inducible nitric oxide by hepatitis B virus transactivator protein HBx requires MTA1 coregulator","volume":"285","author":"Bui-Nguyen","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.niox.2022.07.006_bib156","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/hep.23697","article-title":"c-Jun mediates hepatitis C virus hepatocarcinogenesis through signal transducer and activator of transcription 3 and nitric oxide-dependent impairment of oxidative DNA repair","volume":"52","author":"Machida","year":"2010","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.niox.2022.07.006_bib157","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.bbagen.2011.04.014","article-title":"Regulation of DNA repair by S-nitrosylation","volume":"1820","author":"Tang","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.niox.2022.07.006_bib158","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174326","article-title":"Role of p63 and p73 isoforms on the cell death in patients with hepatocellular carcinoma submitted to orthotopic liver transplantation","volume":"12","author":"Gonzalez","year":"2017","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.niox.2022.07.006_bib159","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bbabio.2008.11.008","article-title":"HCV infection induces mitochondrial bioenergetic unbalance: causes and effects","volume":"1787","author":"Piccoli","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"issue":"10","key":"10.1016\/j.niox.2022.07.006_bib160","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0006-2952(02)01300-X","article-title":"Endoplasmic reticulum (ER) stress: hepatitis C virus induces an ER-nucleus signal transduction pathway and activates NF-kappaB and STAT-3","volume":"64","author":"Waris","year":"2002","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.niox.2022.07.006_bib161","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.gene.2012.10.032","article-title":"Association of eNOS polymorphisms (-786T>C, 4a4b, 894G>T) with colorectal cancer susceptibility in the Korean population","volume":"512","author":"Jang","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.niox.2022.07.006_bib162","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12967-015-0619-5","article-title":"eNOS polymorphisms as predictors of efficacy of bevacizumab-based chemotherapy in metastatic colorectal cancer: data from a randomized clinical trial","volume":"13","author":"Ulivi","year":"2015","journal-title":"J. Transl. Med."},{"issue":"16","key":"10.1016\/j.niox.2022.07.006_bib163","doi-asserted-by":"crossref","first-page":"5258","DOI":"10.1158\/1078-0432.CCR-09-0685","article-title":"Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a Southwest Oncology Group clinical trial","volume":"15","author":"Choi","year":"2009","journal-title":"Clin. Cancer Res. : an official journal of the American Association for Cancer Research"},{"issue":"3","key":"10.1016\/j.niox.2022.07.006_bib164","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s12032-015-0493-2","article-title":"Radiation sensitization with sodium nitrite in patients with brain metastases: a pilot randomized controlled trial","volume":"32","author":"Hosseini","year":"2015","journal-title":"Med. Oncol."},{"issue":"2","key":"10.1016\/j.niox.2022.07.006_bib165","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.radonc.2014.01.021","article-title":"Phase II study. Concurrent chemotherapy and radiotherapy with nitroglycerin in locally advanced non-small cell lung cancer","volume":"111","author":"Arrieta","year":"2014","journal-title":"Radiother. Oncol. : journal of the European Society for Therapeutic Radiology and Oncology"},{"issue":"2","key":"10.1016\/j.niox.2022.07.006_bib166","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.surg.2015.04.007","article-title":"Phase I dose escalation trial of nitroglycerin in addition to 5-fluorouracil and radiation therapy for neoadjuvant treatment of operable rectal cancer","volume":"158","author":"Illum","year":"2015","journal-title":"Surgery"},{"issue":"3","key":"10.1016\/j.niox.2022.07.006_bib167","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00280-016-2967-0","article-title":"ASP9853, an inhibitor of inducible nitric oxide synthase dimerization, in combination with docetaxel: preclinical investigation and a Phase I study in advanced solid tumors","volume":"77","author":"Luke","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"6","key":"10.1016\/j.niox.2022.07.006_bib168","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/tpj.2015.63","article-title":"Polymorphisms of ABCC5 and NOS3 genes influence doxorubicin cardiotoxicity in survivors of childhood acute lymphoblastic leukemia","volume":"16","author":"Krajinovic","year":"2016","journal-title":"Pharmacogenomics J."}],"container-title":["Nitric Oxide"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860322000829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860322000829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:07:53Z","timestamp":1761070073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089860322000829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":168,"alternative-id":["S1089860322000829"],"URL":"https:\/\/doi.org\/10.1016\/j.niox.2022.07.006","relation":{},"ISSN":["1089-8603"],"issn-type":[{"value":"1089-8603","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of nitric oxide in liver cancer microenvironment","name":"articletitle","label":"Article Title"},{"value":"Nitric Oxide","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.niox.2022.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}